Aurora Kinase B Market by Product Type and Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 164 Category: Consumer Goods & Retail Services Report Code : CG116749
Aurora Kinase B Market By Product Type (AZD-2811, Danusertib, CS-2164, Ilorasertib, NMI-900, and Others) and Application (Anaplastic Large Cell Lymphoma, Kidney Cancer, Prostate Cancer, Lung Cancer, and Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Aurora Kinase B Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Aurora B kinase is a protein that capacities in the connection of the mitotic axle to the centromere. Chromosomal isolation during mitosis just as meiosis is directed by kinases and phosphatases. The Aurora kinases partner with microtubules during chromosome development and isolation. Aurora kinase B restricts to microtubules close to kinetochores, explicitly to the specific microtubules called K-strands, and Aurora kinase A (MIM 603072) limits to centrosomes.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Aurora Kinase B Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- AbbVie Inc
- Aeterna Zentaris Inc
- AstraZeneca Plc
- Cielo Therapeutics Inc
- Sareum Holdings Plc
- Advenchen Laboratories LLC
- Amgen Inc
- Chipscreen Biosciences Ltd
- Sanofi
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Aurora Kinase B Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o AZD-2811
o Danusertib
o CS-2164
o Ilorasertib
o NMI-900
o Others
· Aurora Kinase B Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Anaplastic Large Cell Lymphoma
o Kidney Cancer
o Prostate Cancer
o Lung Cancer
o Others
· Aurora Kinase B Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o AbbVie Inc
o Aeterna Zentaris Inc
o AstraZeneca Plc
o Cielo Therapeutics Inc
o Sareum Holdings Plc
o Advenchen Laboratories LLC
o Amgen Inc
o Chipscreen Biosciences Ltd
o Sanofi
· Aurora Kinase B Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Aurora Kinase B Market, By Country
o U.S. Aurora Kinase B Market
o Canada Aurora Kinase B Market
o Mexico Aurora Kinase B Market
o Europe
§ Europe Aurora Kinase B Market, By Country
o Germany Aurora Kinase B Market
o UK Aurora Kinase B Market
o France Aurora Kinase B Market
o Russia Aurora Kinase B Market
o Italy Aurora Kinase B Market
o Rest of Europe Aurora Kinase B Market
o Asia-Pacific
§ Asia-Pacific Aurora Kinase B Market, By Country
o China Aurora Kinase B Market
o Japan Aurora Kinase B Market
o South Korea Aurora Kinase B Market
o India Aurora Kinase B Market
o Southeast Asia Aurora Kinase B Market
o Rest of Asia-Pacific Aurora Kinase B Market
o South America
§ South America Aurora Kinase B Market
o Brazil Aurora Kinase B Market
o Argentina Aurora Kinase B Market
o Columbia Aurora Kinase B Market
o Rest of South America Aurora Kinase B Market
o Middle East and Africa
§ Middle East and Africa Aurora Kinase B Market
o Saudi Arabia Aurora Kinase B Market
o UAE Aurora Kinase B Market
o Egypt Aurora Kinase B Market
o Nigeria Aurora Kinase B Market
o South Africa Aurora Kinase B Market
o Rest of MEA Aurora Kinase B Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Aurora Kinase B Market, By Product Type
5.1. Introduction
5.2. Global Aurora Kinase B Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global Aurora Kinase B Revenue and Revenue Share by Product Type (2017-2027)
5.3. AZD-2811
5.3.1. Global AZD-2811 Revenue and Growth Rate (2017-2027)
5.4. Danusertib
5.4.1. Global Danusertib Revenue and Growth Rate (2017-2027)
5.5. CS-2164
5.5.1. Global CS-2164 Revenue and Growth Rate (2017-2027)
5.6. Ilorasertib
5.6.1. Global Ilorasertib Revenue and Growth Rate (2017-2027)
5.7. NMI-900
5.7.1. Global NMI-900 Revenue and Growth Rate (2017-2027)
5.8. Others
5.8.1. Global Others Revenue and Growth Rate (2017-2027)
6. Aurora Kinase B Market, By Application
6.1. Introduction
6.2. Global Aurora Kinase B Revenue and Market Share by Application (2017-2027)
6.2.1. Global Aurora Kinase B Revenue and Revenue Share by Application (2017-2027)
6.3. Anaplastic Large Cell Lymphoma
6.3.1. Global Anaplastic Large Cell Lymphoma Revenue and Growth Rate (2017-2027)
6.4. Kidney Cancer
6.4.1. Global Kidney Cancer Revenue and Growth Rate (2017-2027)
6.5. Prostate Cancer
6.5.1. Global Prostate Cancer Revenue and Growth Rate (2017-2027)
6.6. Lung Cancer
6.6.1. Global Lung Cancer Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Aurora Kinase B Market, By Region
7.1. Introduction
7.2. Global Aurora Kinase B Revenue and Market Share by Regions
7.2.1. Global Aurora Kinase B Revenue by Regions (2017-2027)
7.3. North America Aurora Kinase B by Countries
7.3.1. North America Aurora Kinase B Revenue and Growth Rate (2017-2027)
7.3.2. North America Aurora Kinase B Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Aurora Kinase B by Countries
7.4.1. Europe Aurora Kinase B Revenue and Growth Rate (2017-2027)
7.4.2. Europe Aurora Kinase B Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Aurora Kinase B by Countries
7.5.1. Asia-Pacific Aurora Kinase B Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Aurora Kinase B Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Aurora Kinase B by Countries
7.6.1. South America Aurora Kinase B Revenue and Growth Rate (2017-2027)
7.6.2. South America Aurora Kinase B Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Aurora Kinase B by Countries
7.7.1. Middle East and Africa Aurora Kinase B Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Aurora Kinase B Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. AbbVie Inc
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Aeterna Zentaris Inc
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. AstraZeneca Plc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Cielo Therapeutics Inc
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Sareum Holdings Plc
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Advenchen Laboratories LLC
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Amgen Inc
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Chipscreen Biosciences Ltd
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Sanofi
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Aurora Kinase B Market Forecast (2017-2027)
9.1. Global Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Aurora Kinase B Market Forecast by Regions (2017-2027)
9.2.1. North America Aurora Kinase B Market Forecast (2017-2027)
9.2.1.1. United States Aurora Kinase B Market Forecast (2017-2027)
9.2.1.2. Canada Aurora Kinase B Market Forecast (2017-2027)
9.2.1.3. Mexico Aurora Kinase B Market Forecast (2017-2027)
9.2.2. Europe Aurora Kinase B Market Forecast (2017-2027)
9.2.2.1. Germany Aurora Kinase B Market Forecast (2017-2027)
9.2.2.2. France Aurora Kinase B Market Forecast (2017-2027)
9.2.2.3. UK Aurora Kinase B Market Forecast (2017-2027)
9.2.2.4. Russia Aurora Kinase B Market Forecast (2017-2027)
9.2.2.5. Italy Aurora Kinase B Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Aurora Kinase B Market Forecast (2017-2027)
9.2.3. Asia-Pacific Aurora Kinase B Market Forecast (2017-2027)
9.2.3.1. China Aurora Kinase B Market Forecast (2017-2027)
9.2.3.2. Japan Aurora Kinase B Market Forecast (2017-2027)
9.2.3.3. Korea Aurora Kinase B Market Forecast (2017-2027)
9.2.3.4. India Aurora Kinase B Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Aurora Kinase B Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Aurora Kinase B Market Forecast (2017-2027)
9.2.4. South America Aurora Kinase B Market Forecast (2017-2027)
9.2.4.1. Brazil Aurora Kinase B Market Forecast (2017-2027)
9.2.4.2. Argentina Aurora Kinase B Market Forecast (2017-2027)
9.2.4.3. Columbia Aurora Kinase B Market Forecast (2017-2027)
9.2.4.4. Rest of South America Aurora Kinase B Market Forecast (2017-2027)
9.2.5. Middle East and Africa Aurora Kinase B Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Aurora Kinase B Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Aurora Kinase B Market Forecast (2017-2027)
9.2.5.3. Egypt Aurora Kinase B Market Forecast (2017-2027)
9.2.5.4. Nigeria Aurora Kinase B Market Forecast (2017-2027)
9.2.5.5. South Africa Aurora Kinase B Market Forecast (2017-2027)
9.2.5.6. Turkey Aurora Kinase B Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Aurora Kinase B Market Forecast (2017-2027)
9.3. Aurora Kinase B Market Forecast by Product Type (2017-2027)
9.3.1. Aurora Kinase B Forecast by Product Type (2017-2027)
9.3.2. Aurora Kinase B Market Share Forecast by Product Type (2017-2027)
9.4. Aurora Kinase B Market Forecast by Application (2017-2027)
9.4.1. Aurora Kinase B Forecast by Application (2017-2027)
9.4.2. Aurora Kinase B Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Aurora Kinase B Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Aurora Kinase B Revenue and Revenue Share by Product Type (2017-2018)
Figure Global AZD-2811 Revenue and Growth Rate (2017-2018)
Figure Global Danusertib Revenue and Growth Rate (2017-2018)
Figure Global CS-2164 Revenue and Growth Rate (2017-2018)
Figure Global Ilorasertib Revenue and Growth Rate (2017-2018)
Figure Global NMI-900 Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Aurora Kinase B Revenue and Revenue Share by Application (2017-2018)
Figure Global Anaplastic Large Cell Lymphoma Revenue and Growth Rate (2017-2018)
Figure Global Kidney Cancer Revenue and Growth Rate (2017-2018)
Figure Global Prostate Cancer Revenue and Growth Rate (2017-2018)
Figure Global Lung Cancer Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Aurora Kinase B Revenue by Regions (2017-2018)
Figure North America Aurora Kinase B Growth Rate (2017-2018)
Figure North America Aurora Kinase B Revenue and Growth Rate (2017-2018)
Figure North America Aurora Kinase B by Countries (2017-2018)
Figure North America Aurora Kinase B Revenue (Million USD) by Countries (2017-2018)
Figure United States Aurora Kinase B Growth Rate (2017-2018)
Figure United States Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Aurora Kinase B Growth Rate (2017-2018)
Figure Canada Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Aurora Kinase B Growth Rate (2017-2018)
Figure Mexico Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Aurora Kinase B Growth Rate (2017-2018)
Figure Europe Aurora Kinase B Revenue and Growth Rate (2017-2018)
Figure Europe Aurora Kinase B by Countries (2017-2018)
Figure Europe Aurora Kinase B Revenue (Million USD) by Countries (2017-2018)
Figure Germany Aurora Kinase B Growth Rate (2017-2018)
Figure Germany Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Aurora Kinase B Growth Rate (2017-2018)
Figure France Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Aurora Kinase B Growth Rate (2017-2018)
Figure UK Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Aurora Kinase B Growth Rate (2017-2018)
Figure Russia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Aurora Kinase B Growth Rate (2017-2018)
Figure Italy Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Aurora Kinase B Growth Rate (2017-2018)
Figure Rest of Europe Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Aurora Kinase B Growth Rate (2017-2018)
Figure Asia-Pacific Aurora Kinase B Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Aurora Kinase B by Countries (2017-2018)
Figure Asia-Pacific Aurora Kinase B Revenue (Million USD) by Countries (2017-2018)
Figure China Aurora Kinase B Growth Rate (2017-2018)
Figure China Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Aurora Kinase B Growth Rate (2017-2018)
Figure Japan Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Aurora Kinase B Growth Rate (2017-2018)
Figure Korea Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Aurora Kinase B Growth Rate (2017-2018)
Figure India Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Aurora Kinase B Growth Rate (2017-2018)
Figure Southeast Asia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Aurora Kinase B Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Aurora Kinase B Growth Rate (2017-2018)
Figure South America Aurora Kinase B Revenue and Growth Rate (2017-2018)
Figure South America Aurora Kinase B by Countries (2017-2018)
Figure South America Aurora Kinase B Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Aurora Kinase B Growth Rate (2017-2018)
Figure Brazil Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Aurora Kinase B Growth Rate (2017-2018)
Figure Argentina Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Aurora Kinase B Growth Rate (2017-2018)
Figure Columbia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Aurora Kinase B Growth Rate (2017-2018)
Figure Rest of South America Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Aurora Kinase B Growth Rate (2017-2018)
Figure Middle East and Africa Aurora Kinase B Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Aurora Kinase B by Countries (2017-2018)
Figure Middle East and Africa Aurora Kinase B Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Aurora Kinase B Growth Rate (2017-2018)
Figure Saudi Arabia Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Aurora Kinase B Growth Rate (2017-2018)
Figure United Arab Emirates Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Aurora Kinase B Growth Rate (2017-2018)
Figure Egypt Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Aurora Kinase B Growth Rate (2017-2018)
Figure Nigeria Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Aurora Kinase B Growth Rate (2017-2018)
Figure South Africa Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Aurora Kinase B Growth Rate (2017-2018)
Figure Turkey Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Aurora Kinase B Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Aurora Kinase B Revenue (Millions USD) and Growth Rate (2017-2018)
Table AbbVie Inc Aurora Kinase B Financial Overview
Table Aeterna Zentaris Inc Aurora Kinase B Financial Overview
Table AstraZeneca Plc Aurora Kinase B Financial Overview
Table Cielo Therapeutics Inc Aurora Kinase B Financial Overview
Table Sareum Holdings Plc Aurora Kinase B Financial Overview
Table Advenchen Laboratories LLC Aurora Kinase B Financial Overview
Table Amgen Inc Aurora Kinase B Financial Overview
Table Chipscreen Biosciences Ltd Aurora Kinase B Financial Overview
Table Sanofi Aurora Kinase B Financial Overview
Figure Global Aurora Kinase B Revenue (Millions USD) and Growth Rate (2018-2025)
Table Aurora Kinase B Market Forecast by Regions (2018-2025)
Figure North America Aurora Kinase B Market Forecast (2018-2025)
Figure United States Aurora Kinase B Market Forecast (2018-2025)
Figure Canada Aurora Kinase B Market Forecast (2018-2025)
Figure Mexico Aurora Kinase B Market Forecast (2018-2025)
Figure Europe Aurora Kinase B Market Forecast (2018-2025)
Figure Germany Aurora Kinase B Market Forecast (2018-2025)
Figure France Aurora Kinase B Market Forecast (2018-2025)
Figure UK Aurora Kinase B Market Forecast (2018-2025)
Figure Russia Aurora Kinase B Market Forecast (2018-2025)
Figure Italy Aurora Kinase B Market Forecast (2018-2025)
Figure Rest of Europe Aurora Kinase B Market Forecast (2018-2025)
Figure Asia-Pacific Aurora Kinase B Market Forecast (2018-2025)
Figure China Aurora Kinase B Market Forecast (2018-2025)
Figure Japan Aurora Kinase B Market Forecast (2018-2025)
Figure Korea Aurora Kinase B Market Forecast (2018-2025)
Figure India Aurora Kinase B Market Forecast (2018-2025)
Figure Southeast Asia Aurora Kinase B Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Aurora Kinase B Market Forecast (2018-2025)
Figure South America Aurora Kinase B Market Forecast (2018-2025)
Figure Brazil Aurora Kinase B Market Forecast (2018-2025)
Figure Argentina Aurora Kinase B Market Forecast (2018-2025)
Figure Columbia Aurora Kinase B Market Forecast (2018-2025)
Figure Rest of South America Aurora Kinase B Market Forecast (2018-2025)
Figure Middle East and Africa Aurora Kinase B Market Forecast (2018-2025)
Figure Saudi Arabia Aurora Kinase B Market Forecast (2018-2025)
Figure United Arab Emirates Aurora Kinase B Market Forecast (2018-2025)
Figure Egypt Aurora Kinase B Market Forecast (2018-2025)
Figure Nigeria Aurora Kinase B Market Forecast (2018-2025)
Figure South Africa Aurora Kinase B Market Forecast (2018-2025)
Figure Turkey Aurora Kinase B Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Aurora Kinase B Market Forecast (2018-2025)
Figure Global Aurora Kinase B Forecast by Product Type (2018-2025)
Figure Global Aurora Kinase B Market Share Forecast by Product Type (2018-2025)
Figure Global Aurora Kinase B Forecast by Product Type (2018-2025)
Figure Global Aurora Kinase B Forecast by Application (2018-2025)
Figure Global Aurora Kinase B Market Share Forecast by Application (2018-2025)
Figure Global Aurora Kinase B Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|